Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Biolargo Inc (OP:BLGO)

0.0988 -0.0002 (-0.20%)

Streaming Delayed Price Updated: 3:41 PM EDT, Sep 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	754,593
Open	0.1009
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0990
Today's Range	0.0936 - 0.1047
52wk Range	0.0763 - 0.2304
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More

September 10, 2026

Partnership backed by a conditional grant commitment from Emissions Reduction Alberta to in support of $4.6 CAD million project, with commercial trials already underway in northern Alberta

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time

September 09, 2026

From BioLargo, Inc

Via ACCESS Newswire

Performance

YTD	-47.4%	-47.4%
1 Month	-4.7%	-4.7%
3 Month	-17.7%	-17.7%
6 Month	-41.7%	-41.7%
1 Year	-57.0%	-57.0%

More News

BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution

September 03, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026

September 01, 2026

From BioLargo, Inc.

Via ACCESS Newswire

BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York

August 25, 2026

From BioLargo, Inc

Via ACCESS Newswire

Gabelli To Host 4th Annual PFAS Symposium

August 24, 2026

From Gabelli Funds

Via GlobeNewswire

BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%

August 17, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo's Lake Stockholm AEC Installation passes six months of PFAS remediation Topping Two Million Gallons

August 03, 2026

From BioLargo, Inc.

Via ACCESS Newswire

BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of Directors

July 30, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Equipment Solutions & Technologies' "PFAS Lady" to Teach PFAS 101 at 41st Annual Tri-State Seminar

July 29, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly

July 27, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales

July 13, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals

July 01, 2026

From BioLargo, Inc

Via ACCESS Newswire

BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets

May 05, 2026

Via ACCESS Newswire

BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology

May 04, 2026

Via ACCESS Newswire

BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026

May 04, 2026

Via ACCESS Newswire

BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery

April 20, 2026

Via ACCESS Newswire

BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum

April 01, 2026

Via ACCESS Newswire

BioLargo Reports Annual 2025 Operating and Financial Results

March 05, 2026

Via ACCESS Newswire

BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time

March 04, 2026

Via ACCESS Newswire

BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium

February 18, 2026

Via ACCESS Newswire

BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution

February 09, 2026

Via ACCESS Newswire

BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST

January 16, 2026

Via ACCESS Newswire

BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation

December 29, 2025

Via ACCESS Newswire

BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough

December 03, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Biolargo Inc publicly traded?

Yes, Biolargo Inc is publicly traded.

What exchange does Biolargo Inc trade on?

Biolargo Inc trades on the OTC Traded

What is the ticker symbol for Biolargo Inc?

The ticker symbol for Biolargo Inc is BLGO on the OTC Traded

What is the current price of Biolargo Inc?

The current price of Biolargo Inc is 0.0988

When was Biolargo Inc last traded?

The last trade of Biolargo Inc was at 09/11/26 03:41 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.